SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS)
IONS 76.28-1.3%Jan 16 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sonny who wrote (2131)7/23/1998 2:06:00 AM
From: tom jones  Read Replies (3) of 4676
 
To all: The fda approval does not mean that antisense technology works. In fact Isis could not show that antisense was taking place with their drug ISIS 2922. ISIS 2922 was injected locally so it did not have to travel through the body where it could be destroyed. If antisense is working here (which I hope it is) there is still a very big problem of getting the drug to where it is needed in other uses. Antisense will only be proven after they show that a few more drugs work which will take a couple more years.
Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News